Total planned funding: $1,242,734,233
Clear active filters
Chemonics International
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $272,102,981 |
Tanzania | $219,094,318 |
Zambia | $215,811,880 |
Mozambique | $137,237,701 |
Uganda | $80,528,442 |
Zimbabwe | $76,492,216 |
Democratic Republic of the Congo | $49,704,557 |
Haiti | $33,592,964 |
Rwanda | $30,762,763 |
Ethiopia | $29,821,296 |
Eswatini | $15,065,135 |
Côte d'Ivoire | $10,550,789 |
Vietnam | $10,497,498 |
South Africa | $8,076,885 |
Burundi | $7,799,057 |
West Africa Region | $5,678,527 |
Namibia | $5,286,094 |
Ukraine | $5,248,771 |
Lesotho | $5,054,620 |
Malawi | $4,816,979 |
Cameroon | $4,514,684 |
Angola | $2,764,049 |
Western Hemisphere Region | $2,048,556 |
Asia Regional Program | $1,814,606 |
Botswana | $1,617,948 |
Kenya | $1,464,539 |
Indonesia | $1,300,000 |
Ghana | $1,010,959 |
Central America Region | $921,400 |
South Sudan | $691,359 |
Caribbean Region | $512,660 |
Burma | $500,000 |
Cambodia | $350,000 |
Organizational Types
Private Contractor | $1,242,734,233 |
Program Areas
Treatment | $997,600,055 |
Care | $75,032,579 |
Prevention | $60,200,766 |
Testing | $57,920,203 |
Governance and Systems | $51,980,630 |
Budget Codes
HTXD: Treatment: ARV Drugs | $624,863,134 |
HTXS: Treatment: Adult Treatment | $303,059,312 |
PDTX: Treatment: Pediatric Treatment | $69,677,609 |
HVCT: Testing: HIV Testing and Counseling | $57,920,203 |
OHSS: Health Systems Strengthening | $46,277,369 |
HVTB: Care: TB/HIV | $41,069,758 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $25,947,222 |
HBHC: Care: Adult Care and Support | $25,598,326 |
HVOP: Sexual Prevention: Other Sexual Prevention | $25,432,967 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $8,515,172 |
PDCS: Care: Pediatric Care and Support | $7,759,214 |
HLAB: Laboratory Infrastructure | $4,147,833 |
HVSI: Strategic Information | $1,555,428 |
HKID: Care: Orphans and Vulnerable Children | $605,281 |
HMIN: Biomedical Prevention: Injection Safety | $287,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $18,405 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
Top Partner Programs
Chemonics International:
$1,242,734,233
View countries